Drug Topics May 2020

"I have to admit that in all 39 years of my career as a community pharmacist, I have never seen a drug that was the center of such intense political discussion."

New digital health products are providing more insight into data and the opportunity for real-time patient interaction.

Heart disease is so common among Americans that it claims 1 life every 37 seconds.

Pharmacists are often the most accessible health care professionals, which is why a lack of access to pharmacies can have a detrimental effect on patients, especially those with chronic conditions. 

Thank you to pharmacy staff on the front lines. 

Fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo) is indicated for treating adults with unresectable or metastatic HER2-positive breast cancer who have received 2 or more prior anti-HER2–based regimens in the setting of metastasis.

The current pandemic could lead to heightened demand for retail pharmacists and pharmacy technicians. 

Investigators are evaluating a variety of medications for the novel coronavirus disease 2019 (COVID- 19), and the possible treatment landscape is rapidly evolving.

In the face of COVID-19, pharmacists continue to provide accessible care to patients.

Never before have so many brilliant minds, machines, and groups come together so quickly in an attempt to develop a vaccine.

If health care were a country, it would be the fifth largest emitter of greenhouse gases worldwide.

Insulin manufacturers are expanding insulin affordability options for patients with diabetes during the coronavirus pandemic. 

In a video interview with Drug Topics®, Robert Brunault, PharmD, a clinical pharmacy specialist of hematology and oncology at Rhode Island Hospital and Lifespan Cancer Institute, answers questions about how the COVID-19 pandemic affects patients undergoing treatment for cancer.

Pharmacies, just as expected, have showed up in meaningful ways to support their communities.

Officials with the FDA have requested that manufacturers of all ranitidine (Zantac) drugs, both prescription and over-the-counter, remove their products from the market. 

What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.